EMKinetics
PrivateLast Round
Debt
Feb 6, 2014
Total Funding Raised
$11.4M
Company Overview
EMKinetics operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Debt round in February 2014.
EMKinetics is a clinical-stage medical technology company that develops neuromodulation therapies based on its Transdermal Stimulation (TranStim) technology to treat urinary incontinence and overactive bladder.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EMKinetics Comparables
Compare EMKinetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exodus Innovations | 79% | |
| NinaMED | 78% | |
| Avation Medical | 77% |
For institutional investors. Book with your work email.
EMKinetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 6, 2014 | ||||
| Series C | Jul 22, 2011 | ||||
| Series B | Sep 9, 2010 | ||||
| Series A Extension | Nov 18, 2009 | ||||
| Series A | Jun 22, 2009 |
For institutional investors. Book with your work email.
EMKinetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scientific Health Development | Series C, Series A Extension, Series A, Series B |
| Oakwood Medical | Series C |
| Easton-Hunt Capital Partners, L.P. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 6, 2014
$1M debt round completed.
- Jul 22, 2011
$8M round led by Allergan, Inc.
For institutional investors. Book with your work email.
EMKinetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EMKinetics's valuation, stock price, and market status.
Is EMKinetics a public or private company?
EMKinetics is a private company.
What is the current stock price of EMKinetics?
EMKinetics is a private company, so its shares have no public market price. Caplight tracks EMKinetics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EMKinetics worth (valuation)?
Valuation information for EMKinetics is not publicly available.
Can I buy EMKinetics stock?
EMKinetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EMKinetics's last funding round?
EMKinetics's most recent funding round was Debt on February 6, 2014.
Who are the main investors in EMKinetics?
Key investors in EMKinetics include Scientific Health Development, Oakwood Medical, Easton-Hunt Capital Partners, L.P..
Will EMKinetics IPO soon?
No public IPO plans have been announced for EMKinetics.
How can I track EMKinetics secondary market activity?
Caplight tracks bids, offers, and trades in EMKinetics's shares on secondary markets.